Literature DB >> 21385167

Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.

Hui Nie1, Jing Cheng, Dylan S Small.   

Abstract

In many clinical studies with a survival outcome, administrative censoring occurs when follow-up ends at a prespecified date and many subjects are still alive. An additional complication in some trials is that there is noncompliance with the assigned treatment. For this setting, we study the estimation of the causal effect of treatment on survival probability up to a given time point among those subjects who would comply with the assignment to both treatment and control. We first discuss the standard instrumental variable (IV) method for survival outcomes and parametric maximum likelihood methods, and then develop an efficient plug-in nonparametric empirical maximum likelihood estimation (PNEMLE) approach. The PNEMLE method does not make any assumptions on outcome distributions, and makes use of the mixture structure in the data to gain efficiency over the standard IV method. Theoretical results of the PNEMLE are derived and the method is illustrated by an analysis of data from a breast cancer screening trial. From our limited mortality analysis with administrative censoring times 10 years into the follow-up, we find a significant benefit of screening is present after 4 years (at the 5% level) and this persists at 10 years follow-up.
© 2011, The International Biometric Society.

Entities:  

Mesh:

Year:  2011        PMID: 21385167     DOI: 10.1111/j.1541-0420.2011.01575.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  18 in total

1.  Semiparametric transformation models for causal inference in time to event studies with all-or-nothing compliance.

Authors:  Wen Yu; Kani Chen; Michael E Sobel; Zhiliang Ying
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2015-03-01       Impact factor: 4.488

2.  Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials.

Authors:  Peter B Gilbert; Bryan E Shepherd; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

3.  Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument-outcome confounders.

Authors:  Sai H Dharmarajan; Yun Li; Douglas Lehmann; Douglas E Schaubel
Journal:  Biom J       Date:  2020-12-21       Impact factor: 2.207

4.  Instrumental variables estimation of exposure effects on a time-to-event endpoint using structural cumulative survival models.

Authors:  Torben Martinussen; Stijn Vansteelandt; Eric J Tchetgen Tchetgen; David M Zucker
Journal:  Biometrics       Date:  2017-05-10       Impact factor: 2.571

5.  Instrumental variable estimation in a survival context.

Authors:  Eric J Tchetgen Tchetgen; Stefan Walter; Stijn Vansteelandt; Torben Martinussen; Maria Glymour
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

6.  Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods.

Authors:  Fei Wan; Dylan Small; Justin E Bekelman; Nandita Mitra
Journal:  Stat Med       Date:  2015-03-20       Impact factor: 2.373

7.  Estimating the Causal Effect of Treatment in Observational Studies with Survival Time Endpoints and Unmeasured Confounding.

Authors:  Jaeun Choi; A James O'Malley
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2016-06-27       Impact factor: 1.864

8.  Latent class instrumental variables: a clinical and biostatistical perspective.

Authors:  Stuart G Baker; Barnett S Kramer; Karen S Lindeman
Journal:  Stat Med       Date:  2015-08-04       Impact factor: 2.373

9.  Instrumental variable methods for causal inference.

Authors:  Michael Baiocchi; Jing Cheng; Dylan S Small
Journal:  Stat Med       Date:  2014-03-06       Impact factor: 2.373

10.  Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.

Authors:  Todd A MacKenzie; Magnus Løberg; A James O'Malley
Journal:  Obs Stud       Date:  2016-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.